Copyright
©The Author(s) 2023.
World J Gastroenterol. Oct 14, 2023; 29(38): 5383-5394
Published online Oct 14, 2023. doi: 10.3748/wjg.v29.i38.5383
Published online Oct 14, 2023. doi: 10.3748/wjg.v29.i38.5383
Figure 2 Dynamic changes of major laboratory test parameters and Child-Pugh/model for end-stage liver disease scores during the 12-mo follow-up.
A: Alanine aminotransferase; B: Aspartate aminotransferase; C: Albumin; D: Total bilirubin; E: Creatinine; F: Platelets; G: International normalized ratio; H: Child-Pugh score; I: Model for end-stage liver disease score. aP < 0.05. BL: Baseline; 3D: Postoperative day 3; 1M: One month postoperatively; 3M: Three months postoperatively; 6M: Six months postoperatively; 12M: Twelve months postoperatively; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALB: Albumin; TBIL: Total bilirubin; CR: Creatinine; PLT: Platelets; INR: International normalized ratio; MELD: Model for end-stage liver disease.
- Citation: Gao L, Li MB, Li JY, Liu Y, Ren C, Feng DP. Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria. World J Gastroenterol 2023; 29(38): 5383-5394
- URL: https://www.wjgnet.com/1007-9327/full/v29/i38/5383.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i38.5383